Pharmacists in Stanford, California


28 Pharmacists found in Stanford
female pharmacist

Nadia Zargham, PHARMD


Pharmacist
300 Pasteur Dr, Stanford, CA 94305
650-723-4000    

female pharmacist

Nicole Lee, PHARMD


Pharmacist
300 Pasteur Dr Rm H0301, Stanford, CA 94305
650-723-5970    

female pharmacist

Nicole Shannon Truong, PHARMD


Pharmacist
300 Pasteur Dr, Stanford, CA 94305
650-723-8363    



male pharmacist

Noah Chung Fang, PHARMD


Pharmacist
300 Pasteur Dr, Stanford, CA 94305
650-723-8363    

female pharmacist

Dr. Pollyanna Yeung


Pharmacist
866 Campus Dr, Stanford, CA 94305
650-815-2000     650-815-2001

male pharmacist

Dr. Raymond Chow, PHARMD


Pharmacist
300 Pasteur Dr, Stanford Hospital, Stanford, CA 94305
650-740-9315    

female pharmacist

Sabrina Lynn Bulla, PHARMD


Pharmacist
300 Pasteur Dr Rm H0301, Stanford, CA 94305
650-723-8363    

female pharmacist

Sandy On, PHARMD


Pharmacist
875 Blake Wilbur Dr, 2nd Floor Clinic G Hematology, Stanford, CA 94304
626-203-3514    

female pharmacist

Dr. Sandy Samir Sallam, PHARMD


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
300 Pasteur Dr, Room, H0301, Mc 5616, Stanford, CA 94305
650-723-8363    

female pharmacist

Dr. Vanessa Amanda Guzman, PHARMD


Pharmacist
300 Pasteur Dr, Stanford, CA 94305
951-285-4580    

female pharmacist

Dr. Veronica Raquel Madrigal, PHARMD


Pharmacist
300 Pasteur Dr Rm H0301mc, Stanford, CA 94305
510-754-3515    

male pharmacist

Dr. William Thomas Moy, PHARMD


Pharmacist
300 Pasteur Dr, H0301, M/c 5616, Stanford, CA 94305
650-725-5205    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.